Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 Prostatic Neoplasms 12 Multiple Myeloma 8 Neoplasm Metastasis 6 Osteoporosis 4 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Lung Neoplasms 2 Kidney Neoplasms 2 Bone Diseases 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Osteonecrosis 1 Oligodendroglioma 1 Neovascularization, Pathologic 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Micrometastasis 1 Nasopharyngeal Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Lymphoma 1

Interventions

Gemcitabine 13 Doxorubicin 8 Docetaxel 7 Trabectedin 5 pazopanib 4 Nivolumab 4 Temozolomide 3 Specimen Handling 3 Sorafenib 3 rucaparib 2 pembrolizumab 2 liposomal doxorubicin 2 durvalumab 2 brostallicin 2 Sunitinib 2 Radiotherapy 2 Radiation Dose Hypofractionation 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ifosfamide 2 Dacarbazine 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tremelimumab 1 talimogene laherparepvec 1 sotigalimab 1 soblidotin 1 saracatinib 1 rubitecan 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leiomyosarcoma × Zoledronic Acid × Clear all

NCT05080790 2025-08-17

DiTuSarc

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡